Rheumatoid arthritis: Update on the newest DMARDs and their potential place in therapy

In the last four years, four new disease modifying antirheumatic drugs have become available. Schrand discusses how the drugs are dramatically changing the treatment of rheumatoid arthritis.

Bibliographische Detailangaben

Veröffentlicht in:	Formulary (Cleveland, Ohio) Ohio), 2002-06, Vol.37 (6), p.301
Hauptverfasser:	Schrand, Linda M, Tuetken, Rebecca
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis Clinical trials Cytokines Drug dosages Drug therapy FDA approval Immunosuppressive agents Nonsteroidal anti-inflammatory drugs Patients Pharmaceutical research Prescription drugs Rheumatoid arthritis Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!